5/A

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: February 28, 2017
Period of Report: December 31, 2016
Accession Number: 0001078782-17-000274

View Document ↗ View on SEC.gov ↗